Investigator Initiated Trials

ACADIA is committed to supporting investigator initiated trials (IIT) with the goal of improving patient’s health and quality of life by increasing the medical and scientific knowledge around pimavanserin. An IIT may be a clinical or non-clinical study for which ACADIA provides funding, drug product, or both. For clinical studies, our particular focus is research in trials which evaluate outcomes in adult patients with central nervous system disorders treated with pimavanserin. Requests outside of this area will not be considered. We support programs that will:

Contribute knowledge to the medical and scientific community;

Address unmet needs; and

Be communicated in an appropriate scientific forum, including peer-reviewed publications.

Examples of appropriate requestors of IIT support include, but are not limited to:

Healthcare providers

Members of the scientific community

Healthcare institutions

Colleges and universities

Government research institutions

IIT Requests

To submit an IIT proposal, please register and complete an online application.Click here.